Pharma’s Outsourcing Model Preferences Revealed in ISR’s New Report

Cary, N.C. – November 17, 2015 – Industry Standard Research (ISR) is announcing the availability of a new report titled Clinical Development Outsourcing Models (2nd edition). This report reveals sponsors’ satisfaction and preferences with seven different outsourcing models, their reasons for model selection, and how each model is used.  It also provides insight into how … Continued

Pfizer CentreSource Lands a Top 3 Position Across All 4 CMO Scorecards in ISR’s Latest Contract Manufacturer Quality Benchmarking Report

Cary, N.C. – June 9, 2015 – Industry Standard Research (ISR) today announced the availability of the “Contract Manufacturer Quality Benchmarking (2015)” report, providing a comprehensive assessment of CMO service quality. This report provides a Consumer Reports-style analysis of CMO quality with respondents giving rating assessments for 481 service encounters across 36 contract manufacturers. Each … Continued

Orphan drug boom comes with a steady stream of outsourcing

With the FDA approving a record number of orphan drugs in 2014, sponsors weren’t the only ones to reap profits from their development. https://www.outsourcing-pharma.com/Clinical-Development/Orphan-drug-boom-comes-with-a-steady-stream-of-outsourcing

ISR Projects a 7.4% Compound Annual Growth Rate for the CRO Market through 2019

Informing the drug development and commercialization industry Cary, N.C. – February 11, 2015 – Industry Standard Research (ISR Reports) has announced the availability of a new report titled “2015 Edition of the CRO Market Size Projections: 2012-2019.” For this report, ISR has utilized both publically available information and data obtained through its syndicated primary market … Continued

Triangle CROs adopt innovative methods to recruit clinical trial patients

Companies that help pharmaceutical and biotechnology companies conduct clinical trials are increasingly focused on unclogging what can be a major bottleneck – recruiting sufficient numbers of patients willing to test an experimental drug in a reasonable period of time. The stakes are high for these contract research organizations, or CROs – an industry that is … Continued

MPI Research, BioReliance among top performers in ISR’s inaugural Preclinical CRO Quality Benchmarking Study

Informing the drug development and commercialization industry Cary, N.C. – January 28, 2015 – Industry Standard Research (ISR) has announced the availability of a new report titled, “CRO Quality Benchmarking – Preclinical Service Providers.” This report provides a Consumer Reports-style analysis of 446 service encounters across 42 preclinical CROs. “Each of these preclinical CROs was … Continued

ISR CUSTOMERS